Post-approval studies (Phase 4)UnknownNCT05786989
What this trial is testing
Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma
Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Chongqing University Cancer Hospital 32